Literature DB >> 35857080

Catheter Intervention for Flow Regulatory Clips on Palliative Shunts and Conduits in Patients with Congenital Heart Disease.

Yuji Doi1,2, Sung-Hae Kim3, Mizuhiko Ishigaki3, Keisuke Sato3, Jun Yoshimoto3, Norie Mitsushita3, Masaki Nii3, Akio Ikai4, Kisaburo Sakamoto4, Yasuhiko Tanaka3.   

Abstract

Catheter intervention (CI) for a Blalock-Taussig shunt (BTS) or a ventricle-to-pulmonary artery conduit (VPC) is often required after a palliative surgery for congenital heart disease. Flow regulatory clips help improve interstage mortality; their use necessitates CIs to prevent cyanosis. To study the CI outcomes in patients who underwent palliative surgery with either BTSs or VPCs with flow regulatory clips. This single-center retrospective study evaluated demographic characteristics and interventional outcomes of 49 consecutive pediatric patients who required CI for BTS (BTS group) or VPC (VPC group) between January 2008 and September 2018. Overall, 34 and 18 procedures were performed in the BTS and VPC groups, respectively. Moreover, 19/32 (59.3%) and 12/17 (70.1%) patients from the BTS and VPC groups had flow regulatory clips, respectively. All clips were unclipped successfully; one patient in each group underwent staged unclipping. A higher proportion of "clipped patients" underwent CI due to desaturation [clipped vs. non-clipped: BTS, 10/20 (50.0%) vs. 3/14 (21.4%), p = 0.092; VPC, 9/13 (69.2%) vs. 1/5 (20.0%), p = 0.060]. Most clipped patients successfully progressed to the next stage [BTS, 19/20 (95.0%); VPC, 12/13 (92.3%)]. Severe adverse events (SAEs) were more frequent in the VPC group than in the BTS group [3/13 (23.1%) vs. 0/20 (0%), p = 0.024]. Two patients developed an atrioventricular block (requiring an atropine infusion), while one died due to pulmonary overcirculation. While the indication of CI was cyanosis for a higher proportion of clipped patients, all clips were unclipped successfully. The incidence of CI-related SAEs was higher in the VPC group than in the BTS group.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adverse events; Blalock–Taussig shunt; Catheter intervention; Clipping; Congenital heart disease; Ventricle-to-pulmonary artery conduit

Year:  2022        PMID: 35857080     DOI: 10.1007/s00246-022-02967-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.838


  18 in total

1.  Temporary restriction of right ventricle-pulmonary artery conduit flow using haemostatic clips following Norwood I reconstruction: potential for improved outcomes.

Authors:  Bari Murtuza; Timothy J Jones; David J Barron; William J Brawn
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-12-08

2.  Endovascular stents for relief of cyanosis in single-ventricle patients with shunt or conduit-dependent pulmonary blood flow.

Authors:  Christopher J Petit; Matthew J Gillespie; Jacqueline Kreutzer; Jonathan J Rome
Journal:  Catheter Cardiovasc Interv       Date:  2006-08       Impact factor: 2.692

3.  Transcatheter Treatment of Thrombosis in the Single Ventricle Pathway: An Institutional Experience.

Authors:  Yaser A Diab; Karthik Ramakrishnan; Fahad A Alfares; Conor F Hynes; Reginald Chounoune; Venkat Shankar; Joshua P Kanter; Dilip S Nath
Journal:  Congenit Heart Dis       Date:  2015-06-09       Impact factor: 2.007

4.  Interstage management of pulmonary blood flow after the Norwood procedure with right ventricle-to-pulmonary artery conduit.

Authors:  Takashi Yasukawa; Takaya Hoashi; Masataka Kitano; Masatoshi Shimada; Kenta Imai; Kenichi Kurosaki; Hajime Ichikawa
Journal:  Eur J Cardiothorac Surg       Date:  2020-09-01       Impact factor: 4.191

5.  Balloon angioplasty for obstructed modified systemic-pulmonary artery shunts and pulmonary artery stenoses.

Authors:  J K Wang; M H Wu; C I Chang; I S Chiu; H C Lue
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

6.  Major Adverse Events Following Over-Shunting Are Associated With Worse Outcomes Than Major Adverse Events After a Blocked Systemic-to-Pulmonary Artery Shunt Procedure.

Authors:  Kok Wai Soo; Johann Brink; Yves d'Udekem; Warwick Butt; Siva P Namachivayam
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

Review 7.  Transcatheter treatment for systemic-to-pulmonary artery shunt obstruction in infants and children.

Authors:  Matthew J Gillespie; Jonathan J Rome
Journal:  Catheter Cardiovasc Interv       Date:  2008-06-01       Impact factor: 2.692

8.  Treatment of right ventricle to pulmonary artery conduit stenosis in infants with hypoplastic left heart syndrome.

Authors:  Andrea Münsterer; Jelena Kasnar-Samprec; Jürgen Hörer; Julie Cleuziou; Andreas Eicken; Ivan Malcic; Rüdiger Lange; Christian Schreiber
Journal:  Eur J Cardiothorac Surg       Date:  2013-03-07       Impact factor: 4.191

9.  Right ventricle-to-pulmonary artery shunt: alternative palliation in infants with inadequate pulmonary blood flow prior to two-ventricle repair.

Authors:  Scott M Bradley; Can C Erdem; Tain-Yen Hsia; Andrew M Atz; Varsha Bandisode; Jeremy M Ringewald
Journal:  Ann Thorac Surg       Date:  2008-07       Impact factor: 4.330

10.  CRISP: Catheterization RISk score for Pediatrics: A Report from the Congenital Cardiac Interventional Study Consortium (CCISC).

Authors:  David G Nykanen; Thomas J Forbes; Wei Du; Abhay A Divekar; Jaxk H Reeves; Donald J Hagler; Thomas E Fagan; Carlos A C Pedra; Gregory A Fleming; Danyal M Khan; Alexander J Javois; Daniel H Gruenstein; Shakeel A Qureshi; Phillip M Moore; David H Wax
Journal:  Catheter Cardiovasc Interv       Date:  2015-11-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.